Načítá se...
New Therapeutic Options for the Treatment of Sickle Cell Disease
Sickle cell disease (SCD; ORPHA232; OMIM # 603903) is a chronic and invalidating disorder distributed worldwide, with high morbidity and mortality. Given the disease complexity and the multiplicity of pathophysiological targets, development of new therapeutic options is critical, despite the positiv...
Uloženo v:
| Vydáno v: | Mediterr J Hematol Infect Dis |
|---|---|
| Hlavní autoři: | , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Università Cattolica del Sacro Cuore
2019
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6328043/ https://ncbi.nlm.nih.gov/pubmed/30671208 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4084/MJHID.2019.002 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|